Cell biology; cell culture and expansion; gene editing using lentiviral vectors or CRISPR/Cas9; assessment of genomic stability of stem cells and their differentiation products; animal models for cancer; immune cell biology and function assays; differentiation of pluripotent stem cells into T cells, Natural Killer (NK) cells, macrophages and other immune cell types; Immune cell killing […]
Cartherics is a biotechnology company focused on developing innovative cancer therapies. We have developed CAR-T cells that are derived from the blood of cancer patients that are genetically modified and expanded for their therapy for solid tumours (ovarian and gastric cancers). Our primary focus is now on therapies that involve gene editing stem cells made […]
We are based in Victoria, Australia.
Cartherics’ mission is the development of novel, “off-the-shelf” (allogeneic) immune cell therapy products for the treatment of cancer.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd